Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score

Por Robertson, Stephanie, Acs, Balazs, Lippert, Michael, Hartman, Johan
Publicado no Breast Cancer Res Treat (2020)

Multiplex quantitative analysis of tumor-infiltrating lymphocytes and immunotherapy outcome in metastatic melanoma

Por Wong, Pok Fai, Wei, Wei, Smithy, James W., Acs, Balazs, Toki, Maria I., Blenman, Kim R.M., Zelterman, Daniel, Kluger, Harriet M., Rimm, David L.
Publicado no Clin Cancer Res (2019)

Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer

Por Gupta, Swati, Neumeister, Veronique, McGuire, John, Song, Yan S., Acs, Balazs, Ho, Kenneth, Weidler, Jodi, Wong, Wendy, Rhees, Brian, Bates, Michael, Rimm, David L., Bossuyt, Veerle
Publicado no NPJ Breast Cancer (2019)

An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma

Por Acs, Balazs, Ahmed, Fahad Shabbir, Gupta, Swati, Wong, Pok Fai, Gartrell, Robyn D., Sarin Pradhan, Jaya, Rizk, Emanuelle M., Gould Rothberg, Bonnie, Saenger, Yvonne M., Rimm, David L.
Publicado no Nat Commun (2019)

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

Por Ács, Balázs, Zámbó, Veronika, Vízkeleti, Laura, Szász, A. Marcell, Madaras, Lilla, Szentmártoni, Gyöngyvér, Tőkés, Tímea, Molnár, Béla Á., Molnár, István Artúr, Vári-Kakas, Stefan, Kulka, Janina, Tőkés, Anna-Mária
Publicado no Diagn Pathol (2017)

In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular a...

Por Ágoston, Emese Irma, Micsik, Tamás, Ács, Balázs, Fekete, Krisztina, Hahn, Oszkár, Baranyai, Zsolt, Dede, Kristóf, Bodoky, György, Bursics, Attila, Kulka, Janina, Krenács, Tibor, Győrffy, Balázs, Harsányi, László, Szász, A. Marcell
Publicado no Diagn Pathol (2016)

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

Por Bottai, Giulia, Raschioni, Carlotta, Székely, Borbála, Di Tommaso, Luca, Szász, Attila M, Losurdo, Agnese, Győrffy, Balázs, Ács, Balázs, Torrisi, Rosalba, Karachaliou, Niki, Tőkés, Tímea, Caruso, Michele, Kulka, Janina, Roncalli, Massimo, Santoro, Armando, Mantovani, Alberto, Rosell, Rafael, Reis-Filho, Jorge S, Santarpia, Libero
Publicado no NPJ Breast Cancer (2016)

Quantitative Assessment of PD-L1 as an Analyte in Immunohistochemistry Diagnostic Assays using a Standardized Cell Line Tissue Microarray

Por Martinez-Morilla, Sandra, McGuire, John, Gaule, Patricia, Moore, Lauren, Acs, Balazs, Cougot, Delphine, Gown, Allen M., Yaziji, Hadi, Wang, Wei-Lien, Cartun, Richard W., Hornick, Jason L., Sholl, Lynette M., Qiu, Jingxin, Mino-Kenudson, Mari, Yi, Eunhee S., Beasley, Mary Beth, Merrick, Daniel T., Ambaye, Abiy B., Zhang, Zhong J., Walker, Jill, Rimm, David L.
Publicado no Lab Invest (2019)